Spontaneous splenic infarction associated with sumatriptan use

被引：6

作者：

Arora A. ^{[1
]}

Arora S. ^{[1
]}

机构：

[1] Department of Internal Medicine, Western Pennsylvania Hospital, Temple University Program, Pittsburgh, PA 15224

来源：

The Journal of Headache and Pain | 2006年 / 7卷 / 4期

关键词：

Infarction; Spleen; Triptan;

D O I：

10.1007/s10194-006-0291-5

中图分类号：

学科分类号：

摘要：

Triptans are specific agonists of the serotonergic 5-HT1B/1D receptors that have increasingly been used in the treatment of migraine and cluster headaches.Though they are generally considered safe, there have been a few reports of myocardial infarction and stroke associated with triptan use. We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache. © Springer-Verlag Italia 2006.

引用

页码：214 / 216

页数：2

共 11 条

[1]

Mueller L., Galagher R.M., Ciervo C.A., Vasospasm-induced myocardial infarction with sumatriptan, Headache, 36, pp. 329-331, (1996)

[2]

Jayamaha J.E.L., Street M.K., Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan, Intensive Care Med, 21, pp. 82-83, (1995)

[3]

Bellaiche G., Radu B., Boucard M., Ley G., Slama J.-L., Infarctus splénique associé à la prise de zolmitriptan, Gastroenterol Clin Biol, 26, (2002)

[4]

Nores M., Phillips E.H., Morganstern L., Hiatt J.R., The clinical spectrum of splenic infarction, Am Surg, 64, pp. 182-188, (1998)

[5]

Goadsby P.J., Serotonin receptors and the acute attack of migraine, Clin Neurosci, 5, pp. 18-23, (1998)

[6]

Hanko J., Hardebo J.E., Kahrstrom J., Owman C., Sundler F., Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilates pial and peripheral arteries, Neurosci Lett, 57, pp. 91-95, (1985)

[7]

Read S.J., Manning P., McNeil C.J., Hunter A.J., Parsons A.A., Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat: Implications for antimigraine mechanisms, Brain Res, 847, pp. 1-8, (1999)

[8]

Plaffenrath V., Cunin G., Sjonell M.D., Prendergast S., Efficacy and safety of sumatriptan tablets (25 mg, 50 mg and 100 mg) in the acute treatment of migraine: Defining the optimum doses of sumatriptan, Headache, 38, pp. 184-190, (1998)

[9]

Knudsen J.F., Friedman B., Chen M., Goldwasser J.E., Ischemic colitis and sumatriptan use, Arch Intern Med, 158, pp. 1946-1948, (1998)

[10]

Vijayan N., Peacock J.H., Spinal cord infarction during the use of zolmitriptan: A case report, Headache, 40, pp. 57-60, (2000)

← 1 2 →